Localization of interleukin-13 gene-expressing cells in tuberculin reactions and lesional skin from patients with atopic dermatitis

Scandinavian Journal of Immunology

Volumn 49, Issue 4, 1999, Pages 447-453

  Van Der Ploeg, I ^a,c   Matuseviciene, G ^a   Fransson, J ^b   Wahlgren, C F ^b   Olsson, T ^c   Scheynius, A ^a  

^a Division of Clinical Immunology   (Sweden)

^b Div of Dermatology and Venereology   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; TUBERCULIN;

ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; TUBERCULIN TEST;

ADOLESCENT; ADULT; DERMATITIS, ATOPIC; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTERLEUKIN-13; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; RNA, MESSENGER; SKIN; TUBERCULIN TEST;

EID: 0033004998     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00513.x     Document Type: Article

References (25)

1. Romagnani S. Human TH1 and TH2 subsets: Regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992;98:279-85.
2. Worm M, Henz BM. Molecular regulation of human IgE synthesis. J Mol Med 1997;75:440-7.
3. Punnonen J, Aversa G, Cocks BG, et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993;90:3730-4.
4. h2 T cell clones and EBV-transformed B cells. Int Immunol 1995;7:1405-16.
5. Van der Ploeg I, Jeddi Tehrani M, Matuseviciene G, Wahlgren C-F, Fransson J, Scheynius A. IL-13 over-expression in skin is not confined to IgE mediated skin inflammation. Clin Exp Immunol 1997;109:526-32.
6. H2 responses: A key role for the 'natural' immune response? Immunol Today 1992;13:379-81.
7. ElGhazali GE, Paulic S, Andersson G, et al. Number of interleukin-4- and interferon-γ-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: Distinct response profiles depending on the type of antigen used for activation. Eur J Immunol 1993;23:2740-5.
8. Ohmen JD, Hanifin JM, Nickoloff BJ, et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995;154:1956-63.
9. Grewe M, GyufKo K, Schöpf E, Krutmann J. Lesional expression of interferon-γ in atopic eczema. Lancet 1994;343:25-6.
10. H1 response in situ: An immunocytochemical study. J Allergy Clin Immunol 1996;97:828-37.
11. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92:44-7.
12. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: The SCORAD index. Dermatology 1993;186:23-31.
13. Sternberger LA, Joseph SA. The unlabeled antibody method, contrasting colour staining of paired pituitary hormones without anti-body removal. J Histochem Cytochem 1979;27:1424-9,
14. Tengvall Linder M, Johansson C, Zargari A, et al. Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatitis and characterization of their cytokine profiles. Clin Exp Allergy 1996;26:1286-97.
15. van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, et al. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992;90:184-93.
16. Huang SK, Xiao HQ, Kleine-Tebbe J, et al. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 1995;155:2688-94.
17. Pawankar RU, Okuda M, HaSegawa S, Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Resp Crit Care Med 1995;152:2059-67.
18. Hamid Q, Naseer T, Minshall EM, Son YL, Boguniewiez M, Leung DY. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996;98:225-31.
19. Kroegel C, Julius P, Matthys H, Virchov JC, Luttmann W. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: Relationship to interleukin-4 and eosinophil counts. Eur Respir J 1996;9:899-904.
20. Matricardi PM, Nisini R, Pizzolo JG, D'Amelio R. The use of Phadiatop® in mass-screening programmes of inhalant allergies: Advantages and limitations. Clin Exp Allergy 1990;20:151-5.
21. + T cells. J Allergy Clin Immunol 1997;100:792-801.
22. Till S, Durham S, Dickason R, et al. IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-γ expression. Immunology 1997;91:53-7.
23. Tsicopoulos A, Hamid Q, Haczku A, et al. Kinetics of cell infiltration and cytokine messenger RNA expression alter intradermal challenge with allergen and tuberculin in the same atopic individuals. J Allergy Clin Immunol 1994;94:764-72.
24. Zurawski G, de Vries JE. Interleukin-13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19-26.
25. Kueharzik T, Lügering N, Pauels HG, Domschke W, Stoll R. IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells. Clin Exp Immunol 1998:111:152-7.